KymaThera is an biotech startup that develops precision small-molecule drugs targeting diseases like cancer and fibrosis.
KymaThera has raised $80.0M in total funding. The most recent round was Series B. The last funding was announced in October 2026.
KymaThera's investors include Venrock, Foresite Capital, Alta Partners, J. Wood Capital Advisors.
KymaThera is headquartered in San Diego, United States.
KymaThera is an biotech startup that develops precision small-molecule drugs targeting diseases like cancer and fibrosis.
KymaThera is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"KymaThera — Funding & Investors." VCBacked, October 6, 2026, https://www.vcbacked.co/company/kymathera. Accessed November 13, 2026.
VCBacked. (2026). KymaThera — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/kymathera
{{cite web |title=KymaThera — Funding & Investors |url=https://www.vcbacked.co/company/kymathera |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at KymaThera? Request a listing update